Skip to main content

Table 2 Microbiome alterations in clinical cohorts of PD

From: Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies

Ref.

Sample size

Control factors

Method

Microbiota alterations

Alpha diversity

Beta diversity

[86]

PD: 72

non-PD: 72

Onset age > 50 years; age- and sex-matched; no endocrine diseases

16S rRNA V1-3

Family increased: Lactobacillaceae, Verrucomicrobiaceae, Bradyrhizobiaceae, Clostridiales Incertae Sedis IV, Ruminococcaceae; family decreased: Prevotellaceae

nd

sd

[87]

PD: 31

non-PD: 28

Early, L-DOPA-naïve PD; only male; age-matched; diet and smoking habits considered

shotgun

metagenomic

Family/genus increased: Verrucomicrobiaceae (genus Akkermansia); family/genus decreased: Prevotellaceae (genus Prevotella), Erysipelotrichaceae (genus Eubacterium); species increased: Akkermansia muciniphila, Alistipes shahii; species decreased: Prevotella copri, Eubacterium bioforme, Clostridium saccharolyticum

nd

sd

[88]

PD: 24

healthy: 14

Age-, sex-, BMI-matched; no diabetes, infectious diseases or special diets

16S rRNA V3-5

Family increased: Enterobacteriaceae, Veillonellaceae, Erysipelotrichaceae, Coriobacteriaceae, Streptococcaceae, Moraxellaceae, Enterococcaceae; genus increased: Acidaminococcus, Acinetobacter, Enterococcus, Escherichia-Shigella, Megamonas, Megasphaera, Proteus, Streptococcus; genus decreased: Blautia, Faecalibacterium, Ruminococcus

nd

sd

[89]

PD: 76 RBD: 21

healthy: 78

Comorbidities and comedication were documented

16S/18S rRNA V4

Family increased: Verrucomicrobiaceae; genus increased: Akkermansia

nd

sd

[90]

PD: 45

healthy: 45

Spouses as control; no serious chronic illnesses (e.g., diabetes); IBS excluded

16S rRNA V3-4

Genus increased: Clostridium IV, Holdemania, Clostridium XVIII, Butyricicoccus, Anaerotruncus, Aquabacterium, Sphingomonas

sd ( >)

sd

[91]

PD: 64

Control: 64

Age- and sex-matched; dietary habits and medications assessed

16S rRNA V3-4

Family decreased: Prevotellaceae; genus increased: Bifidobacterium; genus decreased: Roseburia

nd

sd

[92]

PD: 193 PSP: 22

MSA: 22

non-PD: 113

39 drug-naïve PD; age-, BMI-, region-matched; spouses as control; dietary habits assessed; autoimmune disease and advanced-stage PD excluded

16S rRNA V3-4

Family increased: Verrucomicrobiaceae, Enterobacteriaceae, Christensenellaceae, Lactobacillaceae, Coriobacteriaceae, Bifidobacteriaceae; family decreased: Lachnospiraceae; genus increased: Akkermansia, Parabacteroides; genus decreased: Roseburia

sd ( >)

sd

[93]

PD: 197

healthy: 103

Age 40–85 years, onset age 40–80 years, disease duration ≤ 12 years; age-matched;

medications, diet, and demographics collected

16S rRNA V4

Family increased: Christensenellaceae, Desulfovibrionaceae; family decreased: Lachnospiraceae; genus increased: Bilophila, Akkermansia; genus decreased: Roseburia, Faecalibacterium

nd

sd

[94]

Training set

PD: 40

healthy: 40

Validation set

PD: 78

healthy: 75

MSA: 40 AD: 25

Spouses as partial control; no serious illness (e.g. heart failure); no chronic disease (e.g., diabetes); lifestyle factors and medications considered

shotgun

metagenomic

Family increased: Carnobacteriaceae, Lactobacillaceae, Rikenellaceae, Streptococcaceae, Synergistaceae

Genus increased: Alistipes, Enterobacter, Gordonibacter, Granulicatella, Holdemania, Lactobacillus, Streptococcus

Species increased: Clostridium_asparagiforme, Clostridium_leptum, Enterobacter_cloacae, Gordonibacter_pamelaeae, Granulicatella_unclassified, Holdemania_filiformis, Lachnospiraceae_bacterium 1_1_57FAA, Lachnospiraceae_bacterium 3_1_57FAA_CT1, Lactobacillus_salivarius, Paraprevotella_clara, Streptococcus_anginosus, Streptococcus_salivarius, Streptococcus_thermophilus

sd ( >)

sd

[95]

PD: 26

Control: 25

Early, L-DOPA-naïve PD; only male; 11 healthy controls, 14 diseased controls had cardiovascular risk factors

shotgun

metagenomic

Species increased: Akkermansia muciniphila, Alistipes shahii, Alistipes obesi, Alistipes ihumii; species decreased: Prevotella copri, Clostridium saccharolyticum, Desulfibrio piger

na

na

[96]

PD: 104

non-PD: 96

91 spouses, 5 siblings as control; diet, lifestyle and housing condition considered

16S rRNA V3-4

Family increased: Christensenellaceae, Verrucomicrobiaceae, Synergistaceae, Catabacteriaceae, Lactobacillaceae; genus increased: Cloacibacillus, Catabacter, Christensenella, Butyrivibrio, Bifidobacterium, Megasphaera; species increased: Bacteroides fragilis, Lactobacillus acidophilus

nd

na

[97]

PD: 490

healthy: 234

Region-matched; 55% controls were spouses

shotgun

metagenomic

Genus: 23 ↑, 11 ↓; species: 55 ↑, 29 ↓

na

sd

[98]

PD: 96

non-PD: 74

Newly diagnosed PD; environmental factors considered; no immunocompromised

16S rRNA V4

Phylum increased: Proteobacteria, Verrucomicrobiota, Actinobacteria; genus increased: Akkermansia, Enterococcus, Hungatella

sd ( <)

sd

  1. < , ↓: a lower abundance in patients with PD compared to controls; > , ↑: a higher abundance in patients with PD compared to controls
  2. PD: Parkinson’s disease, nd: no difference, sd: significant difference, L-DOPA: Levodopa, BMI: body mass index, IBS: irritable bowel syndrome, RBD: rapid eye movement sleep behavior disorder, PSP: progressive supranuclear palsy, MSA: multiple system atrophy, AD: Alzheimer's disease, na: not available